The impact of the tumor immune microenvironment on response to pembrolizumab in patients with microsatellite instability-high endometrial cancer.

被引：0
|
作者：
How, Jeffrey A. [1 ]
Dao, Minghao [1 ]
Euscher, Elizabeth [1 ]
Yates, Melinda [1 ]
Peng, Weiyi [2 ]
Patel, Shrina D. [1 ]
Lu, Karen H. [1 ]
Hwu, Patrick [1 ]
Wang, Linghua [1 ]
Jazaeri, Amir A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Houston, Houston, TX USA
来源：
CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO015
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pembrolizumab in the Treatment of Microsatellite Instability-High Sebaceous Carcinoma: A Case Report With Review of the Literature
    Banerjee, Natasha
    Hossain, Farhana
    Wirtschafter, Eric
    Fathizadeh, Payman
    JCO PRECISION ONCOLOGY, 2020, 4 : 61 - 65
  • [42] Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
    Pietrantonio, Filippo
    Lonardi, Sara
    Corti, Francesca
    Infante, Gabriele
    Elez, Maria Elena
    Fakih, Marwan
    Jayachandran, Priya
    Shah, Aakash Tushar
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Salvatore, Lisa
    Curigliano, Giuseppe
    Cremolini, Chiara
    Ambrosini, Margherita
    Ros, Javier
    Intini, Rossana
    Nappo, Floriana
    Damian, Silvia
    Morano, Federica
    Fuca, Giovanni
    Overman, Michael
    Miceli, Rosalba
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
  • [43] Response to nivolumab and ipilimumab in microsatellite instability-high (MSI-H) cervical carcinoma with acquired resistance to pembrolizumab
    Gim, Gahyun
    Cho, Sukjoo
    Lee, Dongyup
    Park, Jonghanne
    Kim, Leeseul
    Choi, Horyun
    Kang, Cyra Y.
    Vagia, Elena
    Viveiros, Pedro
    Chae, Young Kwang
    CANCER RESEARCH, 2020, 80 (16)
  • [44] The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors
    Corti, Francesca
    Lonardi, Sara
    Intini, Rossana
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Belli, Carmen
    Borelli, Beatrice
    Brambilla, Marta
    Prete, Alessandra A.
    Quara, Virginia
    Antista, Maria
    Fassan, Matteo
    Morano, Federica
    Spallanzani, Andrea
    Ambrosini, Margherita
    Curigliano, Giuseppe
    de Braud, Filippo
    Zagonel, Vittorina
    Fuca, Giovanni
    Pietrantonio, Filippo
    EUROPEAN JOURNAL OF CANCER, 2021, 150 : 155 - 167
  • [45] KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer.
    Le, Dung T.
    Kavan, Petr
    Kim, Tae Won
    Burge, Matthew E.
    Van Cutsem, Eric
    Hara, Hiroki
    Boland, Patrick McKay
    Van Laethem, Jean-Luc
    Geva, Ravit
    Taniguchi, Hiroya
    Crocenzi, Todd S.
    Sharma, Manish
    Atreya, Chloe Evelyn
    Diaz, Luis A.
    Liang, Li Wen
    Marinello, Patricia
    Dai, Tong
    O'Neil, Bert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Anti-programmed Death-1 Immunotherapy for Endometrial Cancer with Microsatellite Instability-High Tumors
    Sobecki-Rausch, Janelle
    Barroilhet, Lisa
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (11)
  • [47] Frequency and characteristic of microsatellite Instability-high cancer in our hospital
    Saito, Akihisa
    Kuraoka, Kazuya
    Ishikawa, Akira
    Zaitsu, Junichi
    Taniyama, Kiyomi
    CANCER SCIENCE, 2021, 112 : 793 - 793
  • [48] Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability-high (MSI-H) colorectal cancer: KEYNOTE-164
    Le, D.
    Kavan, P.
    Kim, T.
    Burge, M.
    Van Cutsem, E.
    Hara, H.
    Boland, P.
    Van Laethem, J.
    Geva, R.
    Taniguchi, H.
    Crocenzi, T.
    Sharma, M.
    Atreya, C.
    Diaz, L.
    Liang, L.
    Marinello, P.
    Dai, T.
    O'Neill, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [49] Impact of RAS mutations on immunologic characteristics of the tumor microenvironment (TME) in patients with microsatellite instability-high (MSI-H) or mismatch-repair-deficient (dMMR) colorectal cancer (CRC).
    Salem, Mohamed E.
    Andre, Thierry
    El-Refai, Sherif Mohamed
    Kopetz, Scott
    Tabernero, Josep
    Sinicrope, Frank A.
    Tie, Jeanne
    George, Thomas J.
    VanCutsem, Eric
    Mauer, Elizabeth
    Lonardi, Sara
    Overman, Michael J.
    Foureau, David
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Designing Trials for Neoadjuvant Immune Checkpoint Inhibition in Microsatellite Instability-High Localized Colorectal Cancer
    Andre, Thierry
    Cohen, Romain
    JCO ONCOLOGY PRACTICE, 2023, 19 (05) : 261 - +
12345